SOX4 and neoplasm: By using DESeq221 for our DGE analysis, we discovered that every tumor in both Group 3 and Group 4 datasets showed an upregulation of the SOX4 gene in the later clones, with 10 out of 13 tumors showing a statistically significant upregulation (Padj < .05) (Figure 6A and B).